These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 937182

  • 1. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.
    Meyer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT.
    Am J Cardiol; 1976 Jul; 38(1):103-8. PubMed ID: 937182
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Haemodynamic effects of dobutamine in patients with coronary artery disease.
    Magnani B, Ambrosioni E, Branzi A, Picchio F, Capitanucci P.
    J Int Med Res; 1977 Jul; 5(1):10-7. PubMed ID: 838109
    [Abstract] [Full Text] [Related]

  • 4. Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
    Bendersky R, Chatterjee K, Parmley WW, Brundage BH, Ports TA.
    Am J Cardiol; 1981 Sep; 48(3):554-8. PubMed ID: 7270460
    [Abstract] [Full Text] [Related]

  • 5. [The value of dobutamine in cardiology].
    Baudet M, Rigaud M, Bardet J, Bourdarias JP.
    Ann Anesthesiol Fr; 1978 Sep; 19(10):863-8. PubMed ID: 35060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Loeb HS, Bredakis J, Gunner RM.
    Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
    Fleck E, Dirschinger J, Rudolph W.
    Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
    [No Abstract] [Full Text] [Related]

  • 13. Influence of hypertonic mannitol on ventricular performance and coronary blood flow in patients.
    Willerson JT, Curry GC, Atkins JM, Parkey R, Horwitz LD.
    Circulation; 1975 Jun; 51(6):1095-100. PubMed ID: 1132099
    [Abstract] [Full Text] [Related]

  • 14. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
    Magorien RD, Unverferth DV, Brown GP, Leier CV.
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):499-505. PubMed ID: 6826960
    [Abstract] [Full Text] [Related]

  • 15. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D, Birkhead J, Mitchell A, Dollery C.
    Lancet; 1974 Aug 17; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract] [Full Text] [Related]

  • 16. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
    Hess W, Brückner JB, Schmidt D, Schweichel E, Tarnow J.
    Z Kardiol; 1977 Oct 17; 66(10):537-44. PubMed ID: 919662
    [Abstract] [Full Text] [Related]

  • 17. Drugs five years later. Dobutamine.
    Leier CV, Unverferth DV.
    Ann Intern Med; 1983 Oct 17; 99(4):490-6. PubMed ID: 6625384
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the hemodynamic effects induced by dobutamine, isoproterenol and dopamine in patients with coronary artery disease (author's transl)].
    Ambrosioni E, Maresta A, Magnani B.
    G Ital Cardiol; 1979 Oct 17; 9(7):708-14. PubMed ID: 540702
    [Abstract] [Full Text] [Related]

  • 19. The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.
    Tuttle RR, Pollock GD, Todd G, MacDonald B, Tust R, Dusenberry W.
    Circ Res; 1977 Sep 17; 41(3):357-64. PubMed ID: 890890
    [No Abstract] [Full Text] [Related]

  • 20. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M, Allegri P, Barbieri E, Cappelletti F, Carrozza A, De Lio U, Maiolino P, Morlino T, Ometto R.
    Boll Soc Ital Cardiol; 1978 Sep 17; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.